Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» naproxcinod
naproxcinod
NicOx Jumps After Dow Reports Naproxcinod May Generate Revenue in Europe
Bloomberg
Wed, 08/18/10 - 07:14 am
NicOx
naproxcinod
Europe
osteoarthritis
FDA asks NicOx for new naproxcinod trial
Fierce Biotech
Thu, 07/22/10 - 10:01 am
FDA
NicOx
naproxcinod
osteoarthritis
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
NicOx Falls After Failing to Win FDA Panel’s Backing
Bloomberg
Thu, 05/13/10 - 08:55 am
FDA
NicOx
naproxcinod
NicOx braces itself for naproxcinod meeting in the USA
Pharma Times, UK
Mon, 05/10/10 - 11:57 am
FDA
NicOx
naproxcinod
NicOx to Sell New Shares as FDA Agrees to Review Arthritis Drug
Bloomberg
Wed, 11/18/09 - 09:34 am
FDA
arthritis
stock offering
NicOx
naproxcinod